Arthritic periosteal tissue from joint replacement surgery: A novel, autologous source of stem cells

Stem Cells Translational Medicine

Volumn 3, Issue 3, 2014, Pages 308-317

  Chang, Hana ^a   Docheva, Denitsa ^b   Knothe, Ulf R ^c   Knothe Tate, Melissa L ^a,d  

^a Case Western Reserve University   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Arthritis; Clinical translation; Differentiation; Osteoarthritis; Periosteum; Regenerative medicine; Rheumatoid arthritis; Stem cell

Indexed keywords

CELL SURFACE MARKER;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DERIVED STROMAL CELL; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HIP ARTHROPLASTY; HISTOLOGY; HUMAN; HUMAN CELL; JOINT PROSTHESIS; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PERIOSTEUM; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RHEUMATOID ARTHRITIS; STEM CELL CULTURE;

ARTHRITIS; CLINICAL TRANSLATION; DIFFERENTIATION; OSTEOARTHRITIS; PERIOSTEUM; REGENERATIVE MEDICINE; RHEUMATOID ARTHRITIS; STEM CELL;

ADULT; AGED; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT, HIP; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; FEMALE; FEMUR NECK; GENE EXPRESSION; HISTOCYTOCHEMISTRY; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MULTIPOTENT STEM CELLS; OSTEOARTHRITIS; PERIOSTEUM; PRIMARY CELL CULTURE;

EID: 84896280723     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0056     Document Type: Article

References (45)

1. Chang H, Knothe Tate ML. Concise review: The periosteum: Tapping into a reservoir of clinically useful progenitor cells. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:480-491.
2. Thirumala S, Goebel WS, Woods EJ. Clinical grade adult stem cell banking. Organogenesis 2009;5:143-154.
3. Badowski MS, Harris DT. Collection, processing, and banking of umbilical cord blood stem cells for transplantation and regenerative medicine. MethodsMol Biol 2012;879:279-290.
4. Ginis I, Grinblat B, Shirvan MH. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods 2012;18:453-463.
5. Dhanasekaran M, Indumathi S, Poojitha R et al. Plasticity and banking potential of cultured adipose tissue derived mesenchymal stem cells. Cell Tissue Bank 2013;14:303-315.
6. Kerkis I, Caplan AI. Stem cells in dental pulp of deciduous teeth. Tissue Eng Part B Rev 2012;18:129-138.
7. De Bari C, Dell'Accio F, Vanlauwe J et al. Mesenchymalmultipotency of adult humanperiosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;54:1209-1221.
8. Knothe Tate ML, Chang H, Moore SR et al. Surgicalmembranesasdirectionaldeliverydevices to generate tissue: Testing in an ovine critical sized defect model. PLoS ONE 2011;6:e28702.
9. Breitbart AS, Grande DA, Kessler R et al. Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast Reconstr Surg 1998;101:567-574; discussion 575-576.
10. Wakitani S, Goto T, Pineda SJ et al. Mesenchymal cell-based repair of large, fullthickness defects of articular cartilage. J Bone Joint Surg Am 1994;76:579-592.
11. Sakaguchi Y, Sekiya I, Yagishita K et al. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-2529.
12. Ng AM, Saim AB, Tan KK et al. Comparison of bioengineered human bone construct from four sources of osteogenic cells. J Orthop Sci 2005;10:192-199.
13. Stockmann P, Park J, von Wilmowsky C et al. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells-a comparison of different tissue sources. J Craniomaxillofac Surg 2012;40:310-320.
14. Siddappa R, Licht R, van Blitterswijk C et al. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 2007;25:1029-1041.
15. Centers for Disease Control and Prevention. FastStats: Inpatient surgery. Available at http://www.cdc.gov/nchs/fastats/insurg.htm. Accessed March 25, 2013
16. Malemud CJ, Schulte ME. Is there a final commonpathway for arthritis? Future Rheumatol 2008;3:253-268.
17. Xue F, Zhang C, He Z et al. Analysis of critical molecules and signaling pathways in osteoarthritis and rheumatoid arthritis. MolMedRep 2013;7:603-607.
18. Duijnisveld BJ, Bigot A, Beenakker KG et al. Regenerative potential of human muscle stem cells in chronic inflammation. Arthritis Res Ther 2011;13:R207.
19. Endres M, Andreas K, KalwitzGet al. Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage 2010;18:1458-1466.
20. Morimoto D, Kuroda S, Kizawa T et al. Equivalent osteoblastic differentiation function of human mesenchymal stem cells from rheumatoid arthritis in comparison with osteoarthritis. Rheumatology (Oxford) 2009;48:643-649.
21. Allen MR, Burr DB. Human femoral neck has less cellular periosteum, and more mineralized periosteum, than femoral diaphyseal bone. Bone 2005;36:311-316.
22. Moore SR, Milz S, Knothe Tate ML. Relation ofhumanperiosteal thickness, cellularity to age and loading history. J Anat 2013 (in press).
23. Karamzadeh R, Eslaminejad MB, Aflatoonian R. Isolation, characterization and comparative differentiation of human dental pulp stem cells derived from permanent teeth by using two differentmethods. J Vis Exp 2012;69:e4372.
24. Futami I, Ishijima M, Kaneko H et al. Isolation and characterization of multipotential mesenchymal cells from the mouse synovium. PLoS ONE 2012;7:e45517.
25. Reich CM, Raabe O, Wenisch S et al. Isolation, culture and chondrogenic differentiation of canine adipose tissue-and bone marrowderived mesenchymal stem cells-a comparative study. Vet Res Commun 2012;36:139-148.
26. McBride SH, Evans SF, Knothe Tate ML. Anisotropic mechanical properties of ovine femoral periosteum and the effects of cryopreservation. J Biomech 2011;44:1954-1959.
27. Evans SF, Parent JB, Lasko CE et al. Periosteum, bone's "smart" bounding membrane, exhibits direction-dependent permeability. J Bone Miner Res 2013;28:608-617.
28. Sauser B. Faster healing for severe fractures. MIT Technology Review 2010. Available at http://www.technologyreview.com/printer_ friendly_article.aspx?id=24711. Accessed March 15, 2011.
29. Knothe UR, Springfield DS. A novel surgical procedure for bridging of massive bone defects. World J Surg Oncol 2005;3:7.
30. Kenny DA. The two-group design. Statistics for the Social and Behavioral Sciences. Boston, MA: Little, Brown, 1987:203-223.
31. Ellis PD. The Essential Guide to Effect Sizes: An Introduction to Statistical Power, Meta-Analysis and the Interpretation of Research Results. Cambridge, U.K.: Cambridge University Press, 2010.
32. Knothe UR, Dolejs S, Miller RM et al. Effects of mechanical loading patterns, bone graft, and proximity to periosteumon bone defect healing. J Biomech 2010;43:2728-2737.
33. Coipeau P, Rosset P, Langonne A et al. Impaireddifferentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients. Cytotherapy 2009;11:584-594.
34. Knothe Tate ML, Falls TD, McBride SH et al. Mechanical modulation of osteochondroprogenitor cell fate. Int J Biochem Cell Biol 2008; 40:2720-2738.
35. Leonardi E, Devescovi V, Perut F et al. Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur. Chir Organi Mov 2008;92:97-103.
36. Hutmacher DW, Sittinger M. Periosteal cells in bone tissue engineering. Tissue Eng 2003;9(suppl 1):S45-S64.
37. Gallay SH, Miura Y, Commisso CN et al. Relationship of donor site to chondrogenic potential of periosteum in vitro. J Orthop Res 1994;12:515-525.
38. Bilkay U, Tokat C, Helvaci E et al. Osteogenic capacities of tibial and cranial periosteum: a biochemical and histologic study. J Craniofac Surg 2008;19:453-458.
39. Jones E, English A, Churchman SM et al. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecularbonein healthandosteoarthritis: Implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum 2010;62:1944-1954.
40. Scharstuhl A, Schewe B, BenzKet al. Chondrogenic potential of human adultmesenchymal stemcells is independent of age or osteoarthritis etiology. STEM CELLS 2007;25:3244-3251.
41. Murphy JM, Dixon K, Beck S et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. ArthritisRheum2002;46:704-713.
42. Jones E, Churchman SM, English A et al. Mesenchymal stem cells in rheumatoid synovium: Enumeration and functional assessment in relation to synovial inflammation level. Ann Rheum Dis 2010;69:450-457.
43. Skalska U, Kontny E, Prochorec-Sobieszek M et al. Intra-articular adipose-derived mesenchymal stem cells from rheumatoid arthritis patients maintain the function of chondrogenic differentiation. Rheumatology (Oxford) 2012;51:1757-1764.
44. Papadaki HA, Kritikos HD, Gemetzi C et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: Evidence for a tumor necrosis factor alpha-mediated effect. Blood 2002;99:1610-1619.
45. De Bari C, Dell'Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 2001;44:85-95.